{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:47:17Z","timestamp":1770515237252,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bioorg.2018.01.023","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T23:17:53Z","timestamp":1517354273000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Moi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Gianfranco","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-6096","authenticated-orcid":false,"given":"Valentina","family":"Onnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.01.023_b0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2018.01.023_b0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.01.023_b0020","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","year":"2009"},{"key":"10.1016\/j.bioorg.2018.01.023_b0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/14756366.2014.913587","article-title":"Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors","volume":"30","author":"Winum","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/138161208783877820","article-title":"Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?","volume":"14","author":"De Simone","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2018.01.023_b0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/med.20112","article-title":"Carbonic anhydrase IX: a new druggable target for the design of antitumor agents","volume":"28","author":"Winum","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2018.01.023_h0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138161208783877956","article-title":"Anticonvulsant sulfonamides\/ sulfamates\/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action","volume":"14","author":"Thiry","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2018.01.023_h0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"#cr-split#-10.1016\/j.bioorg.2018.01.023_b0045.1","doi-asserted-by":"crossref","unstructured":"(a) G. De Simone, C.T. Supuran, In Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications, in: C.T. Supuran, J.-Y. Winum, (Eds.), Wiley, Hoboken, NJ, 2009, pp. 241.","DOI":"10.1002\/9780470508169.ch10"},{"key":"#cr-split#-10.1016\/j.bioorg.2018.01.023_b0045.2","doi-asserted-by":"crossref","unstructured":"(b) C.T. Supuran, Structure and function of carbonic anhydrases, Biochem J. 473 (2016) 2023-2032.","DOI":"10.1042\/BCJ20160115"},{"issue":"sup4","key":"10.1016\/j.bioorg.2018.01.023_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","article-title":"Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium","volume":"31","author":"Margheri","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.01.023_h0065","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase Inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites."},{"key":"10.1016\/j.bioorg.2018.01.023_b0060","first-page":"404","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"2010","author":"De Simone","year":"1804","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.01.023_h0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2018.01.023_h0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2018.01.023_b0070","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0075","unstructured":"ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02215850?term=SLC_0111&rank=1."},{"key":"10.1016\/j.bioorg.2018.01.023_b0080","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0085","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_b0090","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.bmc.2015.07.024","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties","volume":"23","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0105","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0110","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.3390\/ijms18010177","article-title":"Design, synthesis and antifungal activity evaluation of new thiazolin-4-ones as potential lanosterol 14\u03b1-demethylase inhibitors","volume":"18","author":"Stana","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2018.01.023_b0115","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.bmcl.2007.01.081","article-title":"Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors","volume":"17","author":"Chen","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_b0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/14756366.2014.1001756","article-title":"Synthesis of pro-apoptotic indapamide derivatives as anticancer agents","volume":"30","author":"Y\u0131lmaz","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bmc.2009.10.041","article-title":"Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs","volume":"18","author":"Omar","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_h0145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bmc.2006.12.003","article-title":"Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents","volume":"15","author":"Rawal","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0150","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.bmc.2007.01.042","article-title":"Synthesis of 3-[4\u2032-(p-chlorophenyl)-thiazol-2\u2032-yl]-2-[(substituted azetidinone\/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent","volume":"15","author":"Kumar","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_h0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2017.09.026","article-title":"Synthesis, biological evaluation and quantitative structure-activity relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity","volume":"140","author":"Carradori","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0160","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.bmc.2010.04.045","article-title":"Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands","volume":"18","author":"Barros","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14756366.2017.1316494","article-title":"Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives","volume":"32","author":"Carradori","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0140","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1016\/j.bmc.2012.04.003","article-title":"Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors","volume":"20","author":"Barzen","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0145","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1016\/j.bmcl.2005.05.093","article-title":"In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones","volume":"15","author":"Ottan\u00e0","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_b0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","volume":"127","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","article-title":"Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV)","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.01.023_b0160","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.bmc.2015.10.014","article-title":"C.T. Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters","volume":"23","author":"Maresca","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0165","doi-asserted-by":"crossref","first-page":"635 I","DOI":"10.1002\/jhet.118","article-title":"Efficient synthesis of 5-(2-hydroxyethyl)-2-phenylimino- 1,3-thiazolidin-4-ones and 5-(2-hydroxyethyl)-2-phenylamino-4,5-dihydro-1,3-thiazol-4-ones","volume":"46","author":"Vana","year":"2009","journal-title":"Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0170","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.bmc.2010.05.073","article-title":"Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity","volume":"18","author":"Subtel\u2019na","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0175","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmech.2014.04.030","article-title":"Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides","volume":"80","author":"Kumar","year":"2014","journal-title":"Eur J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0215","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0220","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","article-title":"Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging","volume":"32","author":"Zhang","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0225","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bmc.2017.01.008","article-title":"Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties","volume":"25","author":"Altug","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0230","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/14756366.2017.1355307","article-title":"Inhibition of the \u03b2-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates","volume":"32","author":"Nocentini","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0235","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.01.023_h0240","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.bmc.2017.03.026","article-title":"Inhibition of Malassezia globosa carbonic anhydrase with phenols","volume":"25","author":"Entezari","year":"2017","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817308921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817308921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:46:31Z","timestamp":1758613591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206817308921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":49,"alternative-id":["S0045206817308921"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.01.023","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}